Perinatal ocular physiology and ROP in the experimental animal model Robert W. Flower OriginalPaper Pages: 153 - 162
The mouse model of oxygen-induced retinopathy: A suitable animal model for angiogenesis research Glen A. GoleJay BrowningSonia M. Elts OriginalPaper Pages: 163 - 169
Oxygen-induced retinopathy in the rat: Possible contribution of peroxidation reactions John S. Penn OriginalPaper Pages: 179 - 186
The role of hyperoxia in the aetiology of retinopathy of prematurity Alec Garner OriginalPaper Pages: 187 - 193
The pathogenesis of retinopathy of prematurity as it relates to surgical treatment Frank L. KretzerRekha S. MehtaHelen A. Mintz-Hittner OriginalPaper Pages: 205 - 211
Retinopathy of prematurity: Prevalence and treatment over a 20 year period at Pennsylvania Hospital Lois H. JohnsonGraham E. QuinnFrank W. Bowen OriginalPaper Pages: 213 - 222
Incidence, severity and time course of ROP in a randomized clinical trial of vitamin E prophylaxis Graham E. QuinnLois JohnsonFrank W. Bowen OriginalPaper Pages: 223 - 228
Retinopathy of prematurity (ROP): Optimal timing of clinical evaluation and standard procedures A. ReibaldiM. SantoconoG. Pizzo OriginalPaper Pages: 229 - 234
Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP) Earl A. Palmer OriginalPaper Pages: 245 - 251
Critical mass retinopathy of prematurity: What is it and what can you do about it? N. W. Hindle OriginalPaper Pages: 253 - 262
The rationale for cryotherapy with a prophylactic scleral buckle for Zone I threshold retinopathy of prematurity Helen A. Mintz-HittnerFrank L. Kretzer OriginalPaper Pages: 263 - 268
